DOCSLIB.ORG

Medical Marijuana for Cancer Patients

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Medical Marijuana for Cancer Patients Medical Marijuana (Cannabinoid-Derived Products) for Cancer Patients 38 accc-cancer.org | May–June 2020 | OI BY MELODY CHANG, RPH, MBA, BCOP annabis, also known as marijuana, or called a vast number of other slang terms like weed, herb, pot, grass, bud, ganja, and Mary Jane originated in Central Asia but is grown Each state has its own list of the Cworldwide today. Cannabis use for medicinal purposes dates qualifying conditions for which it will back at least 5,000 years, with the earliest reported use being in China around 2700 BC for the relief of pain and cramps.1 allow patients to use medical marijuana. In the United States, cannabis is still a controlled substance These qualifying conditions are different and is classified as a Schedule I agent (a drug with a high potential for abuse and currently no accepted medical use). The U.S. Food in each state; however, in many states and Drug Administration (FDA) has not approved cannabis as a number of conditions are cancer a treatment for cancer or any other medical condition. By federal law, the possession of cannabis is illegal, except within approved related—chemotherapy-induced nausea research settings. However, a growing number of states, territories, and vomiting, anxiety, hepatitis C, and the District of Columbia have enacted laws that decriminalized the recreational and/or medicinal use of marijuana in that specific HIV/AIDS, cachexia (wasting syndrome), area. Cannabis is the fastest growing industry in the world. Accord- and inflammatory bowel disease. ing to Arcview’s market research, regulated marijuana sales in North America totaled $6.9 billion in 2016. Sales are projected to increase to $21.6 billion by the year 2021.2 Over the last few decades, there has been significant interest in the potential use of History and Overview marijuana for a variety of medical conditions. There are more Cannabis is a genus of the family Cannabaceae and has generally than 60 U.S. and international health organizations that support been recognized to contain three main species: sativa, indica, and granting patients immediate legal access to medicinal marijuana ruderalis. Cannabis sativa and Cannabis indica are both prevalent under a physician’s supervision.3 in the United States and other parts of the world. Cannabis sativa This article is intended to provide a general introduction and has been employed for thousands of years, primarily as a source overview regarding some of the important aspects and contem- of a stem fiber (both the plant and the fiber, termedhemp ) and porary issues encountered when navigating the field of medical a resinous intoxicant (the plant and its drug preparations, com- marijuana. monly termed marijuana).4 OI | May–June 2020 | accc-cancer.org 39 Figure 1. A Timeline of Cannabis History in the United States Compassionate Use Marihuana Tax Investigational New Cannabis was Act imposed a U. S. Congress Drug program is introduced into levy of 100 per passed the Boggs established; cannabis Western medicine by ounce of cannabis Act and included is distributed to Surgeon W.B. for non-medical cannabis with patients on a 7 10 11 O’Shaughnessy. use.10 narcotic drugs. case-by-case basis. 1839 1851 193 1942 1951 190 198 1992 Cannabis was Cannabis was Controlled Distribution of included in the removed from the Substance Act cannabis through third edition of the 12th edition of the passes; marijuana the compassionate Pharmacopeia of Pharmacopeia of is classified as a use program is the United States.8 the United Schedule I drug.10 closed to new States.10 patients.11 Traditionally, Cannabis sativa plants are tall, reaching heights Pharmacopoeia of the United States (USP). Subsequent revisions of up to 20 feet, loosely branched, and have long, narrow leaves. of the Pharmacopoeia described in detail how to prepare extracts On the other hand, Cannabis indica plants are short and densely and tinctures of dried cannabis flowers to be used as an analgesic, branched and have wider leaves. hypnotic, and anticonvulsant.8 The cannabis plant produces a resin containing compounds Cannabis was included in marketed products sold in the United called cannabinoids. Cannabinoids, also known as phytocanna- States by Eli Lilly and Company and other pharmaceutical com- binoids, are chemicals in cannabis that cause drug-like effects in panies for the treatment of a variety of conditions and/or disorders, the body, including the central nervous system and the immune including insomnia, migraines, and rheumatism.9 system. To date, more than 100 different cannabinoids have been Growing concerns about cannabis in the early 1900s resulted identified. Among these, Δ9-tetrahydrocannabinol (THC) has in it being outlawed in several states, and the U.S. Treasury received the most attention for being responsible for the intoxi- Department introduced the Marihuana Tax Act in 1937. This cated state (psychoactive) sought by recreational cannabis users. Act imposed a levy of $1.00 per ounce for the medicinal use of Another active cannabinoid is cannabidiol (CBD), which may cannabis and $100 per ounce for non-medical use.10 In 1942, the relieve pain and lower inflammation without causing a “high” American Medical Association removed cannabis from the 12th from the THC.6 The highest concentration of cannabinoids is edition of the Pharmacopeia of the United States.10 In 1951, found in the female flowers of the plant. Congress passed the Boggs Act, which for the first time classified In general, marijuana refers only to the parts of the plant or cannabis with narcotic drugs.10 With the passage of the Controlled derivative products that contain substantial levels of THC. Under Substances Act in 1970, cannabis was classified by Congress as U.S. law, cannabis plants with very low levels of THC (no more a Schedule I drug. Drugs that are Schedule I are distinguished as than 0.3 percent) are not considered marijuana but instead are having no currently accepted medicinal use in the United States. industrial hemp. Other Schedule I substances include heroin, lysergic acid dieth- Cannabis use for medicinal purposes dates back thousands of ylamide, mescaline, and methaqualone.10 Despite its designation years ago. It was introduced into Western medicine in 1839 by as having no medicinal use, cannabis was distributed by the U.S. W.B. O’Shaughnessy, a surgeon who learned of its medicinal government to patients on a case-by-case basis under the Com- properties while working in India for the British East India Com- passionate Use Investigational New Drug program established pany. Its use was credited with reported analgesic, sedative, in 1978. Distribution of cannabis through this program was anti-inflammatory, antispasmodic, and anticonvulsant effects.7 closed to new patients in 1992.11 Figure 1, above, shows a timeline In 1851, cannabis was included in the third edition of the of cannabis’s history in the United States. 40 accc-cancer.org | May–June 2020 | OI Legal Status: Federal and State Laws is a fee for applications, and each state has different limits on the Although federal law prohibits the use of cannabis, some states amounts patients are permitted to purchase. In most cases, the have enacted laws that legalized the recreational and/or medicinal purchasing cost of medical marijuana or medical CBD is not use of marijuana in that specific state.6 In 1996, California voters covered by insurance. passed Proposition 215, making California the first state in the To become a certified marijuana physician, a physician must United States to permit the use of medical marijuana.12 Colorado hold an active license, take a required course, and pass an exam. and Washington became the first two states to legalize the recre- This process varies by state. After completion of the state require- ational use of cannabis in 2012. ments, physicians may apply for certification. States with Medical and Recreational Marijuana Laws Dispensing of Medical Marijuana or CBD Thirty-three states and the District of Columbia have passed As of November 30, 2019, 33 states, the District of Columbia, legislation legalizing marijuana for medical use. Of those, five Guam, Puerto Rico, and the U.S. Virgin Islands have passed have established a role for pharmacists in the dispensing medical marijuana laws (see Figure 2, page 42).13 Among them, process:14 10 states, the District of Columbia, and Guam also have legalized • Arkansas requires every marijuana dispensary to appoint a marijuana for recreational use. Those 10 states are Alaska, pharmacist consultant. California, Colorado, Maine, Massachusetts, Colorado, Nevada, • Connecticut permits only pharmacists to apply for and obtain Oregon, Vermont, and Washington.13 a marijuana dispensary license. States with Medical Cannabidiol (CBD) Laws • Minnesota permits only pharmacists to give final approval There are an additional 14 states—Alabama, Georgia, Indiana, for the distribution of medical marijuana to a patient. Iowa, Kansas, Kentucky, Mississippi, North Carolina, • New York requires a pharmacist to be on the premises and South Carolina, Tennessee, Texas, Virginia, Wyoming, and supervise the activities within a marijuana dispensing facility Wisconsin—where the use of medical marijuana has not been whenever the facility is open or in operation. legalized but a medical CBD law allowing for the use of cannabis • Pennsylvania requires primary marijuana dispensing facilities to have a physician or pharmacist on site when the facility is extracts that are high in CBD but minimum in THC has been open to receive patients and caregivers. passed.13 This is only in instances where a patient with a state- qualifying condition is recommended CBD by his or her Under federal law, no individual, including pharmacists, can provider.13 legally dispense medical marijuana, even in states that have passed Individual state laws are all different. Under Florida’s medical medical marijuana legislation.
Load more

Recommended publications
  • Michael H. Daub Attorney at Law 10249 Yellow Circle Drive Suite 102 Minnetonka, Mn 55343
    MICHAEL H. DAUB ATTORNEY AT LAW 10249 YELLOW CIRCLE DRIVE SUITE 102 MINNETONKA, MN 55343 TELEPHONE: (612) 333-1943 E-MAIL: [email protected] February 16, 2021 Representative Zack Stephenson 509 State Office Building St. Paul, MN 55155 In Re: HF 600 Dear Representative Stephenson, I am a drug and substance use disorder policy expert. I am grateful for the opportunity to comment on HF 600 which proposes to regulate adult-use cannabis. There are aspects of HF 600 which I support and some that I oppose. Dr. Karen Randall, a Pueblo, Colorado emergency department physician who specializes in cannabis science and medicine states that “the legalization of marijuana has damaged, rather than helped,” her home state. She goes on to state that, “I think the public needs to know that we are not okay...the grand experiment is not going well. I don’t think the public is hearing about this as they should be.” She adds, “State government has not only ignored scientific findings about marijuana’s effects to push sales, but failed in the regulatory responsibility it promised would accompany legislation.” In support of her statements, she focused on high potency cannabis products, a marked increase in medical problems, misguided impressions of cannabis’ benefits, increased homelessness, and a growing population of chronic, cannabis dependent users. Minnesota sits at a crossroads. Cannabis legalization brings with it difficult legal and policy challenges. Although Minnesota partially decriminalized cannabis in 1976, the legalization movement never gained much momentum. In 2014, Minnesota legalized medical cannabis. Although the federal law criminalizing cannabis, the Controlled Substances Act of 1970 (“CSA”) remains in effect, the budding experiment to legalize cannabis has not withered on the vine.
    [Show full text]
  • CRESCO LABS INC. November 30, 2018 LISTING STATEMENT
    CRESCO LABS INC. November 30, 2018 LISTING STATEMENT - FORM 2A IN CONNECTION WITH THE LISTING OF THE SHARES OF CRESCO LABS INC., THE ENTITY FORMERLY KNOWN AS RANDSBURG INTERNATIONAL GOLD CORP., AFTER THE REVERSE TAKEOVER BY CRESCO LABS, LLC MARIJUANA IS ILLEGAL UNDER U.S. FEDERAL LAW AND THE ENFORCEMENT OF RELEVANT LAWS IS A SIGNIFICANT RISK. Cresco Labs Inc. indirectly holds all the voting interests and an approximate 53% equity interest in Cresco Labs, LLC, the entity through which all of the operating subsidiaries of Cresco Labs, LLC are held. Shareholders are cautioned that at this time, the outstanding Subordinate Voting Shares and Proportionate Voting Shares does not represent all of the equity interest in Cresco Labs, LLC. Cresco Labs Inc. derives a substantial portion of its revenues from the cannabis industry in certain states of the United States, which industry is illegal under United States federal law. Cresco Labs Inc. is indirectly involved (through its licensed subsidiaries) in the cannabis industry in the United States where local state laws permit such activities. Currently, its subsidiaries are directly engaged in the manufacturing, possession, use, sale or distribution of cannabis in the recreational and/or medicinal cannabis marketplace in the States of Illinois, Pennsylvania, Ohio, Nevada, Arizona and California and will begin such activities in New York, Massachusetts and Maryland in the near term. The United States federal government regulates drugs through the Controlled Substances Act, 21 U.S.C. § 811 (the "CSA"), which places controlled substances, including cannabis, in a schedule. Cannabis is classified as a Schedule I drug.
    [Show full text]
  • Report on Medical Cannabis Price Study
    Minnesota Department of Health Office of Medical Cannabis Report on Medical Cannabis Price Study Version 1.2 Submitted by: Bill Brown, Principal Yoko McCarthy, Manager BerryDunn 2211 Congress Street Portland, ME 04102 Table of Contents Table of Contents ......................................................................................................................... i 1.0 Introduction .......................................................................................................................... 1 1.1 Project Background .......................................................................................................... 1 1.2 Office of Medical Cannabis (OMC) ................................................................................... 2 1.3 Registered Medical Cannabis Manufacturers.................................................................... 2 1.4 Products Offered in Minnesota and Definitions ................................................................. 3 2.0 Purpose and Scope .............................................................................................................. 4 2.1 Purpose ............................................................................................................................ 4 2.2 Scope ............................................................................................................................... 4 3.0 Results ................................................................................................................................
    [Show full text]
  • AN ACT Relating to Medicinal Marijuana and Making an Appropriation Therefor
    UNOFFICIAL COPY 20 RS HB 136/HCS 1 1 AN ACT relating to medicinal marijuana and making an appropriation therefor. 2 Be it enacted by the General Assembly of the Commonwealth of Kentucky: 3 SECTION 1. A NEW SECTION OF KRS CHAPTER 218A IS CREATED TO 4 READ AS FOLLOWS: 5 For the purposes of Sections 1 to 30 of this Act, unless the context otherwise requires: 6 (1) "Bona fide practitioner-patient relationship" means a treating or consulting 7 relationship, during the course of which the practitioner: 8 (a) Has completed an initial in-person examination and assessment of the 9 patient's medical history and current medical condition; 10 (b) Has consulted with the patient with respect to the possible therapeutic and 11 palliative properties of medicinal cannabis; 12 (c) Has advised the patient of the possible risks and side effects associated with 13 the use of medicinal cannabis including possible interactions between 14 medicinal cannabis and any other drug or medication that the patient is 15 taking at that time; and 16 (d) Has established an expectation he or she will provide follow-up care and 17 treatment to the patient; 18 (2) "Cannabis business" means a cultivator, dispensary, processor, producer, or a 19 safety compliance facility licensed under this chapter; 20 (3) "Cannabis business agent" means a principal officer, board member, employee, 21 volunteer, or agent of a cannabis business; 22 (4) "Cardholder" means: 23 (a) A registered qualified patient, designated caregiver, or visiting qualified 24 patient who has applied for, obtained,
    [Show full text]
  • Round Table: Legalized Marijuana
    ROUND TABLE Legalized Marijuana June 5 2018 Table of Contents Opening Letter…………………………………………………………………………………………………………………….pg 2 Cannabis Legalization (official release from the Government of Ontario)……………………………..pg 3 Scripture Used to Support Marijuana Use…………………………………………………………………………….pg 7 Scripture Used to Oppose Marijuana Use…………………………………………………………………………….pg 9 The Medical Side of Things………………………………………………………………………………………………..pg 11 When Pot is Legal, What Do We Say?.................................................................................................pg 16 Can Cannabis and Christ Co-exist?.......................................................................................................pg 20 Marijuana to the Glory of God?.............................................................................................................pg 25 Questions to Wrestle Through…………………………………………………………………………………………..pg 29 1 219 Talbot St E Leamington ON N8H 3V6 Tel: 519.326.3605 www.meadowbrook.ca Hello everyone! On Tuesday, June 5th 2018 at 7pm, we will be having a round-table discussion about the legalization of marijuana, which is coming to Canada soon. How do we grapple with this and approach it as Christians, as parents, as a church? We wanted to take some time to get together and talk about the issue. We are not gathering on this night to argue, or to craft an official policy, or to solve the matter once and for all. This will be an ongoing conversation for all of us, requiring prayer and careful thought, and it is likely not going to be
    [Show full text]
  • Legalization of Marijuana and the Conflict with International Drug Control Treaties
    Legalization of Marijuana and the Conflict with International Drug Control Treaties Biju Panicker* Independent Study Spring 2015 Professor Jalila Jefferson-Bullock Abstract The present system of worldwide drug control is based upon three international conventions: the Single Convention on Narcotic Drugs as amended by the 1972 Protocol, the 1971 Convention on Pyschotropic Substances, and the 1988 Convention Against Illicit Trafficking of Narcotic Drugs and Psychotropic Substances. These treaties require participating nations to limit and even criminalize the possession, use, trade, and distribution of drugs outside of medical and scientific purposes, and work together to stop international drug trafficking. This paper argues that the recent move toward legalization of use, possession, and sales of marijuana in the United States (U.S.) and other foreign nations is in conflict with international treaty obligations. While each state in the U.S. has its own drug laws and controlled substances acts, the Supremacy Clause of the U.S. Constitution places international treaties on the same legal footing as federal law. Under this argument, Alaska, Colorado, Oregon, Washington, Washington D.C., as well as Uruguay and The Netherlands’ legalization of marijuana for recreational use, allowance of possession and sales, is in contravention of U.S. federal law and international treaties. Finally, this paper will also look at Portugal’s 2001 decision to decriminalize all drug use to answer the question as to whether the international drug treaties place a “firm limitation” on the legal, “non-medical” sale of schedule drug or truly obligate countries to penalize drug use. Keywords: Marijuana Legalization, International Conventio * © Biju Panicker, J.D.
    [Show full text]
  • HOUSE BILL No. 2303
    Session of 2019 HOUSE BILL No. 2303 By Representatives Finney, Alcala, Ballard, Benson, Carlin, Carmichael, Clayton, Henderson, Highberger, Holscher, Horn, Moore, Ohaebosim, Ousley, Parker, Probst, S. Ruiz, Sawyer, Stogsdill, Victors, Warfield, Winn, Woodard and Xu 2-13 1 AN ACT enacting the Kansas safe access act; providing for the safe, legal, 2 humanitarian and therapeutic use of cannabis for medical conditions; 3 providing for the registration and functions of compassion centers; 4 authorizing the issuance of identification cards; establishing the 5 compassion board; providing for administration of the act by the 6 department of health and environment. 7 8 WHEREAS, Cannabis has been used as a medicine for at least 5,000 9 years and can be effective for serious medical conditions for which 10 conventional medications fail to provide relief; and 11 WHEREAS, Modern medical research has shown that cannabis can 12 slow the progression of such serious diseases as Alzheimer's and 13 Parkinson's, stop HIV and cancer cells from spreading; has both anti- 14 inflammatory and pain-relieving properties; can alleviate the symptoms of 15 epilepsy, post traumatic stress disorder and multiple sclerosis; is useful in 16 the treatment of depression, anxiety and other mental disorders; and can 17 help reverse neurological damage from brain injuries and stroke; and 18 WHEREAS, The world health organization has acknowledged the 19 therapeutic effects of cannabinoids, the primary active compounds found 20 in cannabis, including as an anti-depressant, appetite
    [Show full text]
  • A Survey of Cannabis Consumption and Implications of an Experimental Policy Manipulation Among Young Adults
    Virginia Commonwealth University VCU Scholars Compass Theses and Dissertations Graduate School 2018 A SURVEY OF CANNABIS CONSUMPTION AND IMPLICATIONS OF AN EXPERIMENTAL POLICY MANIPULATION AMONG YOUNG ADULTS Alyssa K. Rudy Virginia Commonwealth University Follow this and additional works at: https://scholarscompass.vcu.edu/etd © The Author Downloaded from https://scholarscompass.vcu.edu/etd/5297 This Thesis is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact [email protected]. A SURVEY OF CANNABIS CONSUMPTION AND IMPLICATIONS OF AN EXPERIMENTAL POLICY MANIPULATION AMONG YOUNG ADULTS A thesis proposal submitted in partial fulfillment of the requirements for the degree of Master of Science at Virginia Commonwealth University. by Alyssa Rudy B.S., University of Wisconsin - Whitewater, 2014 Director: Dr. Caroline Cobb Assistant Professor Department of Psychology Virginia Commonwealth University Richmond, Virginia January, 2018 ii Acknowledgement I would like to first acknowledge Dr. Caroline Cobb for your guidance and support on this project. Thank you for allowing me to explore my passions. I am thankful for your willingness to jump into an unfamiliar area of research with me, and thank you for constantly pushing me to be a better writer, researcher, and person. I would also like to acknowledge the other members of my thesis committee, Drs. Eric Benotsch and Andrew Barnes for their support and expertise on this project. I would also like to thank my family for always supporting my desire to pursue my educational and personal goals.
    [Show full text]
  • Board of Commissioners Meeting Tuesday, March 27, 2018
    City of Henderson, Kentucky Board of Commissioners Meeting Tuesday, March 27, 2018 Municipal Center Third Floor Assembly Room 222 First Street 5:30 P.M. AGENDA 1. Invocation: Brother David Salisbury, Henderson Church of Christ 2. Roll Call: 3. Recognition of Visitors: 4. Appearance of Citizens: 5. Proclamations: "Fair Housing Month" "National Community Development Week" 6. Presentations: George Warren, Audubon Area Homebuilders Chris Heimgartner, HMPL 7. Public Hearings: 8. Consent Agenda: Minutes: March 13, 2018 Regular Meeting March 20, 2018 Special Called Meeting March 20, 2018 Called Work Session 9. Ordinances & Resolutions: Second Readings: Ordinance Amending Code of Ordinances Chapter 20, Streets, Sidewalks, and Other Public Places First Readings: Resolutions: Resolution Authorizing Extension of Sewer Service Outside City Limits - 438 Old Corydon Rd Resolution Accepting Interlocal Cooperation Agreement for the Establishment of a Joint Henderson County and City of Henderson Tourist Commission Please mute or turn off all cell phones for the duration of this meeting. 10. Municipal Orders: Municipal Order Authorizing Donation of Surplus Property to Housing Authority of Henderson- I 021 Clay Street 11. Bids & Contracts: Municipal Order Authorizing the Award of Bid for Mowing of City Cemeteries to Knight's Landscaping 12. Unfinished Business: 13. City Manager's Report: 14. Commissioners' Reports: 15. Appointments: 16. Executive Session: 17. Miscellaneous: Review and Discussion of a Beekeeping Ordinance 18. Adjournment Please mute or turn
    [Show full text]
  • Religious Use of Marijuana Cases
    Summaries of Religious Use of Marijuana Cases Alabama regulate was conceivable, only that none had Rheuark v. State (1992) 601 So.2d 135 been proposed. Statutes prohibiting possession of marijuana and controlled substances did not violate freedom of California: religion rights of defendant claiming that he People v. Mullins (1975) 50 Cal. App 3d 61 worshipped plants as gods and used marijuana Facts: A deputy sheriff had gone to defendant's and psilocybin as religious practice. premises at night at the invitation of a man who Court compared Defendant’s argument to a past lived in a teepee on the property and who had told ruling on polygamy and quoting the cases the officer there were marijuana plants growing Reynolds v. United State 98 U.S. 145 and there. The officer took two plants as samples to Cleveland v. United States 329 U.S. 14 which in be tested and, three days later, went back to the sum says that morality is defined by statute and property with a search warrant. Defendant's Congress and not the individual’s perceptions of property is not enclosed or surrounded by a morality. Therefore because the possession of fence. From Ten Mile Creek Road there is a marijuana is unlawful, it doesn’t matter that the driveway that leads onto defendant's property. Defendant used it for religious use. There is no gate at the entrance to the property. At the entrance there is a sign reading “Universal Arizona: Life Church of Christ Light.” Defendant's wife People v. Hardesty (2009) 214 P.3d 1004 testified that on and prior to May 30, 1972, there FACTS: Hardesty was driving his van at night was a “no trespassing” sign at the entrance to the when an officer stopped him because one property; that a church known as “Universal Life headlight was out.
    [Show full text]
  • HOUSE BILL No. 1547 ___Payne, Teshka, Vannatter
    Introduced Version HOUSE BILL No. 1547 _____ DIGEST OF INTRODUCED BILL Citations Affected: IC 16-18-2; IC 16-31-3-14; IC 16-42-27-2; IC 16-51; IC 22-15-5-16; IC 25-1-1.1-2; IC 34-30-2; IC 35-38-2; IC 35-48; IC 35-52-16. Synopsis: Medical cannabis. Establishes a medical cannabis program, administered by the state department of health, to permit the use of medical cannabis in Indiana. Reduces the penalty for possession of marijuana, hashish, hash oil, and salvia to: (1) a Class C infraction for a first offense; (2) a Class C misdemeanor for a second or subsequent offense; and (3) a Class A misdemeanor for a second or subsequent offense if the person possesses more than a specified amount. Reduces the penalty for possession of marijuana, hashish, hash oil, or salvia packaged in a container labeled as containing low THC hemp extract to a Class C misdemeanor. Provides that a person's probation may not be revoked solely on the basis that the person tested positive for marijuana or a metabolite of marijuana. Makes conforming amendments. Effective: July 1, 2021. Payne, Teshka, VanNatter January 14, 2021, read first time and referred to Committee on Public Health. 2021 IN 1547—LS 6786/DI 106 Introduced First Regular Session of the 122nd General Assembly (2021) PRINTING CODE. Amendments: Whenever an existing statute (or a section of the Indiana Constitution) is being amended, the text of the existing provision will appear in this style type, additions will appear in this style type, and deletions will appear in this style type.
    [Show full text]
  • Fact Sheet Medical Cannabis & Housing
    Medical Marijuana & Housing Fact Sheet Medical Cannabis & Housing Medical Cannabis in Maryland: Overview ● In 2013, the Maryland General Assembly enacted the state’s first legislation creating a framework for the medicinal use of cannabis. Chapter 403 of the Acts of MD 2013 ● A “qualifying patient” may possess up to a 30-day supply of medical cannabis without being subject to arrest, prosecution, or any civil or administrative penalty. The Natalie LaPrade Medical Cannabis Commission will determine what constitutes a 30-day supply. Health-General Article 13–3313(a). ● On June 26, 2015, the Commission published proposed regulations governing the growth, sale, distribution, possession and use of medical cannabis. Maryland Register, Vol. 42, Issue 13, pages 812-45 (June 26, 2015). The comment period closed July 27, 2015, and final regulations are anticipated soon. At this time, medical cannabis is not available for sale or use in Maryland. Federal Law Concerning Marijuana Under the federal Controlled Substances Act, marijuana is categorized as a Schedule 1 drug that has a high potential for abuse and no accepted medical use in treatment in the United States; therefore, use and possession are illegal. 21 U.S.C. §812 Schedule 1(c)(17) ● Despite federal law, as of April 2015, at least 23 states, along with the District of Columbia and Guam, have passed laws exempting qualified users of medical marijuana from penalties imposed under state law, and created state medical marijuana programs. See Colorado Medical Marijuana Code, C.R.S. 12-43.3- 101 et seq.; Hawai’i Uniform Controlled Substances Act, Haw. Rev.
    [Show full text]